Halozyme Therapeutics, Inc.

HALONASDAQ • USD
95.52 USD
↘ 0.98 (1.02%)🟢LIVE (AS OF 11:36 AM EST)
🟢Market: OPEN

Halozyme Therapeutics, Inc. (HALO) is currently trading at $95.52. Technical and fundamental signals converge bearish — technicals rate "Sell" while fundamentals read "Sell". Key drivers include a robust Altman Z-Score, negative Return on Equity and a bullish Golden Cross on the moving averages. HALO is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Nov 16, 2026.

Open?$95.99
High?$98.95
Low?$95.10
Prev. Close?$96.50
Volume?440.9K
Avg. Volume?2.3M
VWAP?$96.07
Rel. Volume?0.19x
Bid / Ask
Bid?$95.55 × 100
Ask?$101.43 × 100
Spread?$5.88
Midpoint?$98.49
Valuation & Ratios
Market Cap?11.0B
Shares Out?114.0M
Float?110.4M
Float %?97.3%
P/E Ratio?22.66
P/B Ratio?-199.17
EPS?$4.26
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.
Employees
423
Market Cap
11.0B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2004-03-12
Address
12390 EL CAMINO REAL
SAN DIEGO, CA 92130
Phone: (858) 794-8889
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
60
Z-Score?
84
Momentum?
91
Short Sent.?
54
Piotroski F-Score?5/9Mixed
Altman Z-Score?3.53Safe
Confidence?74%Moderate
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?12.36%High
Short Interest?13.7M
Days to Cover?6.8
Free Float110.4M
Avg Daily Volume2.0M
Settlement Date2026-10-30
Financial Health
Current Ratio?3.88Strong
Quick Ratio?3.60Strong
Cash Ratio?2.16Strong
Debt/Equity?-58.84Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
78/100
P/E?
Peers
100
S&P
55
22.7FAIR▾
P/B?
S&P
97
-199.17CHEAP▾
P/S?
Peers
100
S&P
21
6.10FAIR▾
P/FCF?
Peers
100
S&P
82
12.4CHEAP▾
EV/EBITDA?
Peers
100
S&P
70
11.6CHEAP▾
EV/Sales?
Peers
100
S&P
19
7.34HIGH▾
Returns & Efficiency
ROE?
S&P
3
-878.8%WEAK▾
ROA?
Peers
50
S&P
85
14.0%STRONG▾
Cash Flow & Enterprise
FCF?$885.9M
Enterprise Value?$13.2B
Fundamentals ratios updated end of day